Business Insider
My Markets Watchlist
Markets Stocks

UnitedHealth Inc. Stock , UNH

303.81 +0.68 +0.22%
03:59:59 PM EDT 6/10/2025 BTT
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar

On Monday 06/09/2025 the closing price of the UnitedHealth Inc. share was $303.13 on BTT. Compared to the opening price on Monday 06/09/2025 on BTT of $304.88, this is a drop of 0.58%. UnitedHealth Inc.'s market capitalization is $226.80 B by 907.14 M shares outstanding.
Is UnitedHealth stock a Buy, Sell or Hold? UnitedHealth stock has received a consensus rating of buy. The average rating score is A2 and is based on 73 buy ratings, 7 hold ratings, and 4 sell ratings.
What was the 52-week low for UnitedHealth stock? The low in the last 52 weeks of UnitedHealth stock was 248.89. According to the current price, UnitedHealth is 122.07% away from the 52-week low.
What was the 52-week high for UnitedHealth stock? The high in the last 52 weeks of UnitedHealth stock was 630.72. According to the current price, UnitedHealth is 48.17% away from the 52-week high.
What are analysts forecasts for UnitedHealth stock? The 84 analysts offering price forecasts for UnitedHealth have a median target of 539.27, with a high estimate of 680.00 and a low estimate of 270.00. The median estimate represents a 56.34 difference from the last price of 303.81.

UnitedHealth Stock Snapshot

302.02
Bid
3.00
Bid Size
330.82
Ask
1.00
Ask Size
6/10/2025
Date
3:59 PM
Time
504.00
Volume
303.13
Prev. Close
0.00
Open
275.58 B
Market Cap in USD
907.14 M
Number of Shares
907.14 M
Total Number of Shares
248.89
52 Week Low
630.72
52 Week High
303.81
8.18
Dividend in USD
1.62
Dividend Yield
32.62
P/E Ratio
99.76
Free Float in %
15.51
EPS in USD
101.27
Book Value per Share in USD
26.05
Cash Flow per Share in USD

Historical Prices for UnitedHealth

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

UnitedHealth Analyst Data

Total Analysts: 84
Buy Ratings: 73 Neutral Ratings: 7 Sell Ratings: 4
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 270.00 Median: 539.27 Highest: 680.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

UnitedHealth Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price
06/03/25 Piper Sandler
Maintained Buy $353
06/02/25 Barclays Capital
Maintained Buy $350
05/21/25 HSBC
Downgraded to Sell $270
05/20/25 Wolfe Research
Maintained Buy $390
05/19/25 TD Securities
Downgraded to Hold $308
05/16/25 Mizuho
Maintained Buy $350
05/16/25 RBC Capital Markets
Maintained Buy $355
05/15/25 Barclays Capital
Maintained Buy $362
05/15/25 J.P. Morgan
Maintained Buy $405
05/14/25 Deutsche Bank
Maintained Buy $362
05/14/25 Oppenheimer & Co. Inc.
Maintained Buy $400
05/14/25 Wells Fargo & Co
Maintained Buy $351
05/14/25 Morgan Stanley
Maintained Buy $374
05/14/25 Bank of America Merrill Lynch
Downgraded to Hold $350
05/14/25 Baird Patrick & Co
Maintained Buy $356
04/29/25 Baird Patrick & Co
Maintained Buy $510
04/24/25 Barclays Capital
Maintained Buy $513
04/24/25 J.P. Morgan
Maintained Buy $525
04/23/25 RBC Capital Markets
Maintained Buy $525
04/22/25 HSBC
Downgraded to Sell
04/22/25 Morgan Stanley
Maintained Buy $563
04/21/25 Argus Research Company
Downgraded to Hold
04/21/25 Barclays Capital
Maintained Buy $560
04/21/25 Raymond James Financial, Inc.
Maintained Buy $540
04/21/25 Oppenheimer & Co. Inc.
Maintained Buy $600
04/09/25 Mizuho
Maintained Buy $650
01/28/25 Wells Fargo & Co
Maintained Buy $660
07/23/24 Cantor Fitzgerald
Maintained Buy $591
07/18/24 UBS
Maintained Buy $680
07/17/24 Argus Research Company
Maintained Buy $600
07/17/24 Barclays Capital
Maintained Buy $604
07/17/24 Cantor Fitzgerald
Maintained Buy $591
07/17/24 Wells Fargo & Co
Maintained Buy $630
07/17/24 RBC Capital Markets
Maintained Buy $615
07/17/24 Jefferies & Company Inc.
Upgraded to Buy $647
07/17/24 Baird Patrick & Co
Maintained Buy $640
07/17/24 Morgan Stanley
Maintained Buy $615
07/09/24 Cantor Fitzgerald
Maintained Buy $591
06/12/24 Cantor Fitzgerald
Maintained Buy $591
05/30/24 J.P. Morgan
Maintained Buy $559
05/30/24 Baird Patrick & Co
Maintained Buy $597
04/19/24 Deutsche Bank
Maintained Buy $562
04/17/24 RBC Capital Markets
Maintained Buy $555
04/17/24 Barclays Capital
Maintained Buy $560
04/17/24 Piper Sandler
Maintained Buy $571
04/10/24 Cantor Fitzgerald
Maintained Buy $591
04/08/24 Wells Fargo & Co
Maintained Buy $525
04/05/24 Morgan Stanley
Maintained Buy $584
04/04/24 HSBC
Upgraded to Sell $460
04/04/24 Cantor Fitzgerald
Maintained Buy $591

UnitedHealth Estimates* in USD

  2025 2026 2027 2028 2029
Revenue 449,571 477,343 508,201 545,784 601,042
Dividend - 9.62 9.93 10.67 -
Dividend Yield (in %) 2.91 % 3.17 % 3.27 % 3.52 % -
EPS 22.46 25.87 29.65 36.05 40.83
P/E Ratio 13.50 11.72 10.22 8.41 7.42
EBIT 29,768 33,171 36,799 43,633 47,830
EBITDA 32,063 39,712 43,675 48,109 52,985
Net Profit 19,848 22,702 25,463 30,565 33,731
Net Profit Adjusted 20,278 23,000 25,907 30,681 33,884
Pre-Tax Profit 25,423 29,350 33,171 39,369 43,217
Pre-Tax Profit Reported 25,031 28,133 30,863 - -
EPS (Non-GAAP) ex. SOE 21.40 25.52 29.66 38.93 44.12
EPS (GAAP) 21.07 24.34 28.11 34.61 39.38
Gross Income 87,654 93,917 101,351 - -
Cash Flow from Investing -5,768 -8,482 -8,997 -13,709 -13,809
Cash Flow from Operations 26,504 29,447 33,002 39,410 43,629
Cash Flow from Financing -13,169 -16,790 -17,772 -17,155 -19,595
Cash Flow per Share 30.65 31.46 35.04 - -
Free Cash Flow 24,526 26,418 29,764 34,457 38,440
Free Cash Flow per Share - - - - -
Book Value per Share 110.23 119.69 131.22 - -
Net Debt 43,772 40,318 34,812 48,804 39,679
Research & Development Exp. - - - - -
Capital Expenditure 3,942 4,110 4,408 4,175 4,385
Selling, General & Admin. Exp. 54,505 57,246 61,315 - -
Shareholder’s Equity 101,498 106,797 113,856 123,194 134,443
Total Assets 315,129 329,090 349,214 390,324 419,316
  Previous Quarter
ending 03/31/25 		Current Quarter
ending 06/30/25 		Next Quarter
ending 09/30/25 		Current Year
ending 12/31/25 		Next Year
ending 12/31/26
Earnings Estimates
No. of Analysts 22 23 23 25 25
Average Estimate 7.296 USD 5.088 USD 5.330 USD 22.462 USD 25.866 USD
Year Ago -1.528 USD 4.578 USD 6.560 USD 15.641 USD -
Publish Date 4/17/2025 7/29/2025 10/21/2025 - -
Revenue Estimates
No. of Analysts 18 19 19 21 21
Average Estimate 111,542 USD 111,812 USD 113,581 USD 449,571 USD 477,343 USD
Year Ago 99,796 USD 98,855 USD 100,820 USD 400,278 USD -
Publish Date 4/17/2025 7/29/2025 10/21/2025 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2024 2023 2022 2021 2020 2019 2018
Sales 400,278.00 367,809.00 324,162.00 287,597.00 257,141.00 242,155.00 226,247.00
Change of sales in % 8.83 13.46 12.71 11.84 6.19 7.03 12.47
Gross profit on sales - - - - - - -
Gross profit on sales change in % - - - - - - -
Operating income 32,287.00 28,545.00 28,438.21 23,970.00 22,405.00 19,685.00 17,344.00
Operating income change in % 13.11 0.38 18.64 6.99 13.82 13.50 14.04
Income before tax 20,071.00 29,112.00 26,343.00 22,310.00 20,742.00 17,981.00 15,944.00
Income before tax change in % -31.06 10.51 18.08 7.56 15.36 12.78 13.70
Income after tax 14,405.00 22,381.00 20,120.00 17,285.00 15,403.00 13,839.00 11,986.00
Income after tax change in % -35.64 11.24 16.40 12.22 11.30 15.46 13.53

Balance Sheet in Mio. USD

2024 2023 2022 2021 2020 2019 2018
Total liabilities 199,511.00 179,496.00 163,955.00 139,275.00 130,141.00 114,595.00 97,995.00
Long-term liabilities per share - - - - - - -
Equity 102,591.00 98,919.00 86,347.00 76,479.00 70,539.00 62,162.00 56,227.00
Equity change in % 4.40 14.12 8.38 9.57 13.67 11.45 8.20
Balance sheet total 302,102.00 278,415.00 250,302.00 215,754.00 200,680.00 176,757.00 154,222.00
Balance sheet total change in % 8.51 11.23 16.01 7.51 13.53 14.61 9.51

Key Data in USD

2024 2023 2022 2021 2020 2019 2018
Sales per share 430.87 392.12 341.22 300.83 267.58 250.68 230.16
P/E ratio (year end quote, basic EPS) 32.62 22.06 25.03 27.77 21.88 20.52 20.43
P/E ratio (year end quote, diluted EPS) 32.62 22.06 25.03 27.77 21.88 20.52 20.43
Dividend yield in % 1.62 1.38 1.21 1.12 1.38 1.41 1.38
Equity ratio in % 33.96 35.53 34.50 35.45 35.15 35.17 36.46
Debt ratio in % 66.04 64.47 65.50 64.55 64.85 64.83 63.54

UnitedHealth Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
Conway Patrick Hugh 06/05/2025 160.26 10,987.45 303.22 Sell No
McSweeney Erin 06/05/2025 130.43 11,075.63 303.22 Sell No
Conway Patrick Hugh 06/04/2025 667.54 11,147.71 295.84 Sell No
Zaetta Christopher R 06/02/2025 115.13 10,192.71 301.22 Sell No
REX JOHN F 06/02/2025 29.50 203,766.54 301.22 Sell No
Conway Patrick Hugh 06/01/2025 1,641.00 11,815.25 n/a Buy No
HEMSLEY STEPHEN J 05/19/2025 2,525.00 374,352.94 n/a Sell No
Gil Kristen 05/14/2025 3,700.00 3,818.00 271.17 Buy No
FLYNN TIMOTHY PATRICK 05/13/2025 1,533.00 6,033.00 320.80 Buy No
Noseworthy John H 05/13/2025 300.00 6,063.00 312.16 Buy No
MONTGOMERY RICE VALERIE MD 03/31/2025 180.00 6,256.00 n/a Buy No
FLYNN TIMOTHY PATRICK 03/31/2025 180.00 9,123.00 n/a Buy No
Noseworthy John H 03/31/2025 180.00 5,763.00 n/a Buy No
MCNABB FREDERICK WILLIAM III 03/31/2025 183.00 13,656.00 n/a Buy No
HOOPER MICHELE J 03/17/2025 152.00 39,932.00 n/a Buy No
Cianfrocco Heather 03/17/2025 46.07 22,438.32 n/a Buy No
Noel Timothy John 03/17/2025 27.45 9,196.18 n/a Buy No
REX JOHN F 03/17/2025 75.99 186,621.04 n/a Buy No
HEMSLEY STEPHEN J 03/17/2025 31.00 706,819.94 n/a Buy No
Noseworthy John H 03/17/2025 24.00 5,583.00 n/a Buy No
ROOS THOMAS E 03/17/2025 14.50 29,499.07 n/a Buy No
Zaetta Christopher R 03/17/2025 28.64 10,307.84 n/a Buy No
McSweeney Erin 03/17/2025 25.26 11,206.06 n/a Buy No
Baker Charles D. 03/17/2025 4.00 803.00 n/a Buy No
MONTGOMERY RICE VALERIE MD 03/17/2025 24.00 6,076.00 n/a Buy No

UnitedHealth Dividend Calendar

Date Name Dividend *yield Currency
2024 UnitedHealth Inc. 8.18 1.62 USD
2023 UnitedHealth Inc. 7.29 1.38 USD
2022 UnitedHealth Inc. 6.40 1.21 USD
2021 UnitedHealth Inc. 5.60 1.12 USD
2020 UnitedHealth Inc. 4.83 1.38 USD
2019 UnitedHealth Inc. 4.14 1.41 USD
2018 UnitedHealth Inc. 3.45 1.38 USD
2017 UnitedHealth Inc. 2.88 1.30 USD
2016 UnitedHealth Inc. 2.38 1.48 USD
2015 UnitedHealth Inc. 1.88 1.59 USD
2014 UnitedHealth Inc. 1.41 1.39 USD
2013 UnitedHealth Inc. 1.05 1.40 USD
2012 UnitedHealth Inc. 0.80 1.47 USD
2011 UnitedHealth Inc. 0.61 1.21 USD
2010 UnitedHealth Inc. 0.41 1.12 USD
2009 UnitedHealth Inc. 0.03 0.10 USD
2008 UnitedHealth Inc. 0.03 0.11 USD
2007 UnitedHealth Inc. 0.03 0.05 USD
2006 UnitedHealth Inc. 0.03 0.06 USD
2005 UnitedHealth Inc. 0.02 0.03 USD
2004 UnitedHealth Inc. 0.02 0.05 USD
2003 UnitedHealth Inc. 0.01 0.03 USD
2002 UnitedHealth Inc. 0.01 0.05 USD
2001 UnitedHealth Inc. 0.01 0.06 USD
2000 UnitedHealth Inc. 0.01 0.07 USD
1999 UnitedHealth Inc. 0.01 0.15 USD
*Yield of the Respective Date

UnitedHealth Calendar

Event Estimate Info Date
Earnings Report 5.056 USD Q2 2025 Earnings Release 07/29/2025
Earnings Report 5.290 USD Q3 2025 Earnings Release 10/21/2025
Earnings Report 4.649 USD Q4 2025 Earnings Release 01/21/2026
Earnings Report 7.828 USD Q1 2026 Earnings Release 04/22/2026
Earnings Report 6.088 USD Q2 2026 Earnings Release 07/10/2026

UnitedHealth Past Events

Event Actual EPS Info Date
Annual General Meeting 15.510 USD Annual General Meeting 06/02/2025
Earnings Report 6.850 USD Q1 2025 Earnings Release 04/17/2025
Earnings Report 5.980 USD Q4 2024 Earnings Release 01/16/2025
Earnings Report 6.510 USD Q3 2024 Earnings Release 10/15/2024
Earnings Report 4.540 USD Q2 2024 Earnings Release 07/16/2024
Annual General Meeting 23.860 USD Annual General Meeting 06/03/2024
Earnings Report -1.530 USD Q1 2024 Earnings Release 04/16/2024
Earnings Report 5.830 USD Q4 2023 Earnings Release 01/12/2024
Earnings Report 6.240 USD Q3 2023 Earnings Release 10/13/2023
Earnings Report 5.820 USD Q2 2023 Earnings Release 07/14/2023
Annual General Meeting 21.180 USD Annual General Meeting 06/05/2023
Earnings Report 5.950 USD Q1 2023 Earnings Release 04/14/2023
Earnings Report 5.030 USD Q4 2022 Earnings Release 01/13/2023
Earnings Report 5.550 USD Q3 2022 Earnings Release 10/14/2022
Earnings Report 5.340 USD Q2 2022 Earnings Release 07/15/2022
Annual General Meeting 18.080 USD Annual General Meeting 06/06/2022
Earnings Report 5.270 USD Q1 2022 Earnings Release 04/14/2022
Earnings Report 4.260 USD Q4 2021 Earnings Release 01/19/2022

UnitedHealth Profile

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T.

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
3
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

UnitedHealth Management

Name Job
Stephen J. Hemsley Chairman & Chief Executive Officer
Thomas Edward Roos Chief Accounting Officer & Executive VP
Terry M. Clark Chief Customer & Marketing Officer & Executive VP
Richard J. Mattera Chief Development Officer & Senior Vice President
Sandeep Dadlani Chief Digital & Technology Officer & EVP
Dame Vivian Hunt Chief Innovation Officer
Margaret-Mary Wilson Chief Medical Officer & Executive Vice President
Erin L. McSweeney Chief People Officer
Daniel J. Schumacher Chief Strategy & Growth Officer
Patricia L. Lewis Chief Sustainability Officer & Executive VP
Kristi Hummel Chief Talent Officer
Kuai H. Leong Deputy Secretary & Senior Deputy General Counsel
D. Ellen Wilson Executive Vice President
Richard J. Migliori Executive Vice President
Todd Walthall Executive Vice President-Enterprise Growth
Charles D. Baker Independent Director
Frederick William McNabb Independent Director
John H. Noseworthy Independent Director
Kristen L. Gil Independent Director
Paul R. Garcia Independent Director
Timothy Patrick Flynn Independent Director
Valerie C. Montgomery Rice Independent Director
Michele J. Hooper Lead Independent Director
John Franklin Rex President & Chief Financial Officer
Joy Fitzgerald SVP, Chief Diversity, Equity & Inclusion Officer
Christopher R. Zaetta Secretary, Chief Legal Officer & Executive VP
Rupert Mark Boden Bondy Senior Counsel, EVP-Governance & Compliance
Frances Jacobs Senior Vice President-Investor Relations
Zack Sopcak Senior Vice President-Investor Relations
Matthew Shigenobu Muta Senior Vice President-Optum Consumer Engineering
John Walthour Vice President-Strategic Insights